| CTRI Number |
CTRI/2026/02/104599 [Registered on: 24/02/2026] Trial Registered Prospectively |
| Last Modified On: |
23/02/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Comparison of Retrolaminar block and Local anaesthetic infiltration for post operative pain relief in patients undergoing spine surgery |
|
Scientific Title of Study
|
Comparison of postoperative analgesic efficacy between bilateral ultrasound guided Retrolaminar block and local anaesthetic infiltration in patients undergoing Thoraco-lumbar spine surgery – a double blinded prospective
randomized controlled trial |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Saurabh Mishra |
| Designation |
Junior resident |
| Affiliation |
Institute of Medical science, Banaras Hindu University |
| Address |
Department of Anaesthesiology, Institute of Medical sciences, Banaras Hindu University, Varanasi
Varanasi UTTAR PRADESH 221005 India |
| Phone |
7427057781 |
| Fax |
|
| Email |
saurabh.mukeshmishra2000@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Reena |
| Designation |
Associate Professor |
| Affiliation |
Institute of Medical science, Banaras Hindu University |
| Address |
Department of Anaesthesiology, Institute of Medical sciences, Banaras Hindu University, Varanasi
Varanasi UTTAR PRADESH 221005 India |
| Phone |
9628679954 |
| Fax |
|
| Email |
reena@bhu.ac.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Reena |
| Designation |
Associate Professor |
| Affiliation |
Institute of Medical science, Banaras Hindu University |
| Address |
Department of Anaesthesiology, Institute of Medical sciences, Banaras Hindu University, Varanasi
Varanasi UTTAR PRADESH 221005 India |
| Phone |
9628679954 |
| Fax |
|
| Email |
reena@bhu.ac.in |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Sir Sunderlal Hospital IMS BHU |
| Address |
Institute Of Medical Sciences, Banaras Hindu University, Varanasi, 221005, Uttar Pradesh, India |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 2 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Saurabh Mishra |
Department of Neurosurgery |
Trauma Center and Super Speciality Hospital, Institute of Medical Sciences, Banaras Hindu University Varanasi UTTAR PRADESH |
7427057781
saurabh.mukeshmishra2000@gmail.com |
| Dr Saurabh Mishra |
Department of Orthopaedics |
Trauma Center and Super speciality Hospital, Institute Of Medical Sciences, Banaras Hindu University Varanasi UTTAR PRADESH |
7427057781
saurabh.mukeshmishra2000@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics commiittee, Institute of Medical sciences, Banaras Hindu University |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M968||Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Local Anaesthetic Infiltration |
Group L: Wound infiltration at the end of surgery using 40ml 0.2% Ropivacaine |
| Intervention |
Retrolaminar Block |
Group R: Bilateral Ultrasound guided Retrolaminar Block with 20 ml 0.2% Ropivacaine given after induction of general anaesthesia, before skin incision. Duration of block will be measured from placement of ultrasound probe on the skin to complete instillation of 20 ml drug on either side. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1. Patients (age 18 to 65 years) with ASA grade I-III undergoing Thoraco-lumbar spine surgery
under general anaesthesia
2. Patients who can understand and provide a valid consent for the procedure and can
understand and are willing to report the pain using NRS score. |
|
| ExclusionCriteria |
| Details |
1. Patients not giving consent
2. Duration of surgery more than 3 hours
3. Patients with allergies to local anaesthetics
4. Bleeding disorders
5. Anti-coagulant or anti-platelet drugs, INR more than 1.5
6. Localised infections
7. Patients in whom the sono-anatomy of the anaesthetic injection site is not clearly
delineable due to any reason
8. Patients with associated Rib fracture and polytrauma patient with associated head, thoracic,
abdominal injury
9. Patients with previous history of spine surgery |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
To compare the post operative analgesic efficacy assessed by Numeric Rating Scale(NRS),
between Bilateral USG guided Retrolaminar Block and local anaesthetic infiltration in
patients undergoing thoraco-lumbar spine surgery. |
30 min, 1 hour, 2 hour, 6 hour, 12 hour, 24 hour |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
To compare the time to first dose of rescue analgesia intravenous injection (drug
TRAMADOL 1mg/kg) required to achieve adequate analgesia (Numeric Rating Scale less than and equal to 3)
between two groups. |
30 min, 1 hour, 2 hour, 6 hour, 12 hour, 24 hour |
To compare the total dose (in mg) of rescue analgesia intravenous injection (drug
TRAMADOL 1mg/kg) required to achieve adequate analgesia (Numeric Rating Scale less than and equal to 3) in the first 24 hours post surgery between two groups. |
30 min, 1 hour, 2 hour, 6 hour, 12 hour, 24 hour |
| To compare Intraoperative intravenous FENTANYL consumption (0.5mcg/kg intravenous dose given when MAP or HR more than 20% of preoperative values) |
Duration of surgery |
| To compare Total duration of hospital stay |
Duration of hospital stay |
|
|
Target Sample Size
|
Total Sample Size="68" Sample Size from India="68"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
08/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The study will be conducted in Trama Emergency OT, Orthopaedics Elective OT and Neurosurgery Elective OT in Trauma Centre, Institute of Medical Sciences, BHU, Varanasi. After approval from hospital research and ethical committee, a double blinded prospective Randomized study will be conducted on patients coming to IMS, BHU, Varanasi. Once the patients are enrolled, they will be randomized into either Group R or Group L. Randomization will be done using computer generated random number sequence. Allocation concealment will be done using serially numbered opaque sealed envelopes. The process of allocation will be done by a staff member who is not a part of the study group. There will be 68 such sealed opaque envelopes pre-designed with equal numbers of Retrolaminar block and local anaesthetic infiltration. One day prior to the scheduled surgery, all the patients will be instructed on how to evaluate their own pain by using a 10cm Numeric rating pain scale( 0-no pain, 10-maximum pain). In the operating room after attaching the standard ASA monitors and IV lines, the patient will be induced using standardized general anaesthesia protocol as routinely followed in our department. IV induction along with muscle relaxation followed by endotracheal intubation will be done using appropriate size cuffed tube. Mechanical Ventilation will be established with an oxygen-air mixture and titrated to ETCO2 between 35 to 45 mm Hg. Analgesia maintained with Inj. Fentanyl 2mcg/kg at induction given for all patients. Maintenance of anaesthesia will be done using inhalation agent Isoflurane and intermittent muscle relaxant as required. Fluid therapy will be provided according to routine institutional practice. Inj. Dexamethasone 0.1mg/kg IV will be given to all patients at the start of surgery. Inj. Diclofenac 75 mg iv will be given to all patients prior to skin incisions. If MAP or HR is more than equal to 20% from baseline, ruling out hemodynamic causes or insufficient depth of anaesthesia, Inj. Fentanyl 0.5 mcg/kg will be given for intraoperative pain management. Patients will be turned to prone position taking care of endotracheal tube, pressure points, eye, spine and possible nerve injuries. Group R (Retrolaminar Group): Before the incision, the intervention area will be sterilized with povidone iodine and spirit before the procedure, covered by sterile drapes and a sterile sheath will be applied to the ultrasound probe. High frequency linear or curved array probe is selected depending on the patient’s body habitus and depth of the vertebral lamina. The ultrasound probe will be placed sagittally in the midline at the target vertebral level, i.e., intermediate one for surgical level(s) of odd number or the upper or second one for surgical levels of even number. After the spinous processes are seen, the ultrasound probe is moved laterally 1-2 cm and vertebral lamina are observed. A 5-10 cm 22G stimuplex needle is inserted in real time in cranial to caudal direction with in plane technique. When the needle touches the lamina, Inj. Ropivacaine 0.2% 20ml is administered with low pressure. The same intervention will be performed on the other side of the vertebral lamina. Group L (Local anaesthetic infiltration group): Wound infiltration will be performed by the surgeon at the end of the surgery. After hemostasis achieved and before skin closure, 40 mL of 0.20% ropivacaine will be infiltrated into multiple layers of the surgical wound, in prone position. This will include the subcutaneous tissue and muscle layers, ensuring the even distribution of the anesthetic solution to cover the entire surgical area. Inj. Paracetamol 1 gm iv will be given to all patients 15 min, before skin closure. At the end of surgery, Inj. Ondansetron 0.1mg/kg will be given and muscle relaxation will be reversed with Inj. Neostigmine 50 mcg/kg and Inj. Glycopyrrolate 10mcg/kg. The patient will be extubated and the patients will be transferred to Post-Anaesthesia care unit. Once the patients are transferred into wards, all will receive round the clock Inj. Paracetamol 1 gm IV 8 hourly and Inj. Diclofenac 75 mg 12 hourly. For rescue analgesia (when the NRS score will be more than 3) in postoperative period, Inj. Tramadol 1mg/kg will be given. The duration of analgesia will be from administration of block to the first use of rescue analgesia. Total consumption of Inj. Tramadol as rescue analgesic will be recorded in the 24 hour observation period. Incidence of Side Effects: nausea, vomiting and surgical site infection will be recorded as binary outcomes (present/absent). The total length of hospital stay will also be recorded (starting from the day of surgery which will be taken as Day 0). |